Delivery Order SPE2DB22D1017-SPE2DB25FG5DZ
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 18, 2025, by the Defense Logistics Agency for the supply of Trulicity 1.5 mg/0.5 mL pens valued at $7,736.88. The contract carries a firm fixed price structure with no set-aside designation, indicating it was awarded through open competition. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania, with an...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 9, 2025, by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $22,414.82. The contract is a firm fixed price delivery order with an ultimate completion date of September 10, 2025, and was awarded without a set-aside designation through competitive procurement. Performance will be executed at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 7, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pens with a ceiling value of $1,366.59. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 8, 2025, and performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,101.07 by the Defense Logistics Agency (DLA) on July 24, 2025, with an ultimate completion date of July 25, 2025. The contract, utilizing firm fixed pricing with no set-aside designation, calls for the delivery of Trulicity 1.5 mg/0.5 mL pens in 0.5 mL quantities to support federal medical supply needs. This delivery order represents a child contract under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for Trulicity 1.5 mg/0.5 ml pen (0.5 ml) on September 12, 2025. The contract is valued at $1,201.20 under firm fixed-price terms with an ultimate completion date of September 15, 2025. This delivery order is not set-aside and represents a competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,006.00 by the Defense Logistics Agency on August 5, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injections. The contract, designated as firm fixed price with no set-aside provisions, represents a competitively awarded delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitive delivery order award from the Defense Logistics Agency valued at $1,174.94 for Trulicity 0.75 mg/0.5 ml pen medication. The contract carries a firm fixed price structure with an ultimate completion date of July 25, 2025, and was awarded on July 24, 2025. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $22,053.12 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,702.70 by the Defense Logistics Agency (DLA) on June 2, 2025, with an ultimate completion date of June 3, 2025. The delivery order is for Trulicity 1.5 mg/0.5 ml pen injectables and was issued under a firm fixed-price, non-set-aside competitive contract. This child delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,351.35 from the Defense Logistics Agency for Trulicity 1.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. This competitively awarded, firm fixed price delivery order was issued on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract carries no set-aside designation and is performed at the contractor's Conshohocken facility. This delivery order...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG5DZDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,051.05 firm fixed-price delivery order on June 17, 2025, by the Defense Logistics Agency to supply Trulicity 1.5 mg/0.5 ml pens. This delivery order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of June 18, 2025. This award reflects AmerisourceBergen's critical role in supporting the federal medical supply chain, particularly for military and veteran healthcare systems. The broader SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs worldwide, including customers such as the Defense Health Agency and the U.S. Coast Guard. The company's competitively awarded contracts demonstrate its capability to fulfill federal procurement requirements across diverse therapeutic domains, from diabetes medications to specialized medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 6/17/25 |